HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVD

Argos Therapeutics, Inc., Durham NC

Investigators

Abstract

The goal of this Research Program is to design, develop, and clinically test an autologous HIV immunotherapy capable of eliciting therapeutic immune responses and which is comprised of autologous monocyte-derived dendritic cells modified to express selected autologous HIV proteins representing a multiplicity of patient-specific quasispecies